Mr David Charles Wilson, LPC | |
116 Dumaine Pl, Madison, MS 39110-9234 | |
(662) 378-7888 | |
(601) 853-2990 |
Full Name | Mr David Charles Wilson |
---|---|
Gender | Male |
Speciality | Counselor - Professional |
Location | 116 Dumaine Pl, Madison, Mississippi |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184040800 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 0256 (Mississippi) | Primary |
Entity Name | Innovative Behaviorals Services, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578578092 PECOS PAC ID: 7517969850 Enrollment ID: O20070215000315 |
News Archive
A large-scale malaria prevention program through which medical aid group Medecins Sans Frontieres (MSF) gave intermittent doses of anti-malaria drugs to 175,000 children in Mali and Chad suggests that "widely distributing anti-malaria drugs to healthy children in African countries can significantly reduce the number of new cases of the disease," VOA News reports.
A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.
Researchers suggest a possible cell-based therapy to stimulate lung development in fragile premature infants who suffer from a rare condition called Bronchopulmonary Dysplasia, which in the most severe cases can lead to lifelong breathing problems and even death.
Axelar AB today announced that promising data from the ongoing Phase I/II clinical trial concerning their lead anticancer product AXL1717, an insulin-like growth factor-1 (IGF-1) receptor inhibitor, will be presented next week at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, Massachusetts, USA.
The immune response to an H5N1 avian influenza vaccine was greatly enhanced in healthy adults if they were first primed with a DNA vaccine expressing a gene for a key H5N1 protein, researchers say.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mr David Charles Wilson, LPC 116 Dumaine Pl, Madison, MS 39110-9234 Ph: (662) 378-7888 | Mr David Charles Wilson, LPC 116 Dumaine Pl, Madison, MS 39110-9234 Ph: (662) 378-7888 |
News Archive
A large-scale malaria prevention program through which medical aid group Medecins Sans Frontieres (MSF) gave intermittent doses of anti-malaria drugs to 175,000 children in Mali and Chad suggests that "widely distributing anti-malaria drugs to healthy children in African countries can significantly reduce the number of new cases of the disease," VOA News reports.
A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.
Researchers suggest a possible cell-based therapy to stimulate lung development in fragile premature infants who suffer from a rare condition called Bronchopulmonary Dysplasia, which in the most severe cases can lead to lifelong breathing problems and even death.
Axelar AB today announced that promising data from the ongoing Phase I/II clinical trial concerning their lead anticancer product AXL1717, an insulin-like growth factor-1 (IGF-1) receptor inhibitor, will be presented next week at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, Massachusetts, USA.
The immune response to an H5N1 avian influenza vaccine was greatly enhanced in healthy adults if they were first primed with a DNA vaccine expressing a gene for a key H5N1 protein, researchers say.
› Verified 8 days ago
Abigail Campbell, P-LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 940 Ebenezer Blvd, Madison, MS 39110 Phone: 601-790-0583 | |
Kendyl Hensley, BA, MDIV Counselor Medicare: Not Enrolled in Medicare Practice Location: 940 Ebenezer Blvd, Madison, MS 39110 Phone: 601-790-0583 | |
Mrs. Clara Newton, MS, PLPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 505 Cobblestone Ct Ste A, Madison, MS 39110 Phone: 601-540-7422 | |
Breda Faye Hall, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1531 Highland Colony Pkwy, Madison, MS 39110 Phone: 601-506-1459 | |
Dr. Gregory Obert, PH.D., LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7570 Old Canton Rd Ste 102, Madison, MS 39110 Phone: 601-809-5324 | |
Katherine Johnson, PLPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 208 Key Dr Ste C, Madison, MS 39110 Phone: 601-760-2050 | |
Mrs. Pamela Graef Luckett, Counselor Medicare: Not Enrolled in Medicare Practice Location: 109 Cedar Pine Ln, Madison, MS 39110 Phone: 601-214-8160 Fax: 601-856-6356 |